Description: A Monoclonal antibody against Human FGF19 (clone FG98-6). The antibodies are raised in Mouse and are from clone FG98-6. This antibody is applicable in WB and IHC-P, E

Description: A polyclonal antibody against FGF19. Recognizes FGF19 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

Description: A polyclonal antibody against FGF19. Recognizes FGF19 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

Description: FGF19, Fibroblast growth factor 19, is a protein that in humans is encoded by the FGF19 gene. The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. The FGF19 gene is mapped to 11q13.3. The deduced 216-amino acid FGF19 protein contains asignal sequence and 2 cysteine residues that are conserved in the FGF family. Expression of this gene was detected only in fetal but not adult brain tissue. Synergistic interaction of the chick homolog and Wnt-8c has been shown to be required for initiation of inner ear development. FGF19 stimulates hepatic protein and glycogen synthesis but does not induce lipogenesis. The effects of FGF19 are independent of the activity of either insulin or the protein kinase Akt and, instead, are mediated through a mitogen-activated protein kinase signaling pathway that activates components of the protein translation machinery and stimulates glycogen synthase activity. FGF19 is the orthologous protein in humans. They are often referred together as FGF15/19.

Description: FGF19, Fibroblast growth factor 19, is a protein that in humans is encoded by the FGF19 gene. The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. The FGF19 gene is mapped to 11q13.3. The deduced 216-amino acid FGF19 protein contains asignal sequence and 2 cysteine residues that are conserved in the FGF family. Expression of this gene was detected only in fetal but not adult brain tissue. Synergistic interaction of the chick homolog and Wnt-8c has been shown to be required for initiation of inner ear development. FGF19 stimulates hepatic protein and glycogen synthesis but does not induce lipogenesis. The effects of FGF19 are independent of the activity of either insulin or the protein kinase Akt and, instead, are mediated through a mitogen-activated protein kinase signaling pathway that activates components of the protein translation machinery and stimulates glycogen synthase activity. The orthologous protein in mouse is FGF15, which shares about 50% amino acid identity and has similar functions. Together they are often referred to as FGF15/19.

Description: Fibroblast growth factor 19, is a protein that in humans is encoded by the FGF19 gene. The protein encoded by this gene is a member of the fibroblast growth factor(FGF) family. The gene is mapped to 11q13.3. The deduced 216-amino acid FGF19 protein contains asignal sequence and 2 cysteine residues that are conserved in the FGF family. Expression of this gene was detected only in fetal but not adult brain tissue. Synergistic interaction of the chick homolog and Wnt-8c has been shown to be required for initiation of inner ear development. FGF19 stimulates hepatic protein and glycogen synthesis but does not induce lipogenesis. The effects of FGF19 are independent of the activity of either insulin or the protein kinase Akt and, instead, are mediated through a mitogen-activated protein kinase signaling pathway that activates components of the protein translation machinery and stimulates glycogen synthase activity.

Description: A Monoclonal antibody against Human GATA6. The antibodies are raised in Mouse and are from clone 2F10G3. This antibody is applicable in WB, FC, ICC, E

Description: A Monoclonal antibody against Human TNNI2 (clone 2F12G2). The antibodies are raised in Mouse and are from clone 2F12G2. This antibody is applicable in WB and IHC-P, IF, ICC, E, Flo

Description: A Monoclonal antibody against Human ALCAM / CD166 (clone 10F1G12). The antibodies are raised in Mouse and are from clone 10F1G12. This antibody is applicable in IHC-P, E

Description: A Monoclonal antibody against Human FGF4. The antibodies are raised in Mouse and are from clone 2D7D5. This antibody is applicable in E

Description: A Monoclonal antibody against Human FGF4. The antibodies are raised in Mouse and are from clone 3A12G9. This antibody is applicable in WB, E

Description: A recombinant monoclonal antibody from rabbit against human FGF21 for WB ,ELISA

Description: A Monoclonal antibody against Human FGF2. The antibodies are raised in Mouse and are from clone 2H5G2C11. This antibody is applicable in WB and IHC, E

Description: A Monoclonal antibody against Human FGF1 (clone 1F9). The antibodies are raised in Mouse and are from clone 1F9. This antibody is applicable in WB and IHC-P, IF, E

Description: A Monoclonal antibody against Human BANF1 / BAF / BCRP1 (clone 3F10-4G12). The antibodies are raised in Mouse and are from clone 3F10-4G12. This antibody is applicable in WB and IHC-P, E

Description: A Monoclonal antibody against Human FGFR1OP (monoclonal) (M01). The antibodies are raised in mouse and are from clone 2B1. This antibody is applicable in WB and IF, E

Description: A Monoclonal antibody against Human Cytokeratin 19. The antibodies are raised in Mouse and are from clone 4F12G9. This antibody is applicable in WB, E

Description: A Monoclonal antibody against Human FGFR1OP2 (monoclonal) (M01). The antibodies are raised in mouse and are from clone 2G4. This antibody is applicable in WB, E

Description: A Monoclonal antibody against Human FGF1 (clone 2E12). The antibodies are raised in Mouse and are from clone 2E12. This antibody is applicable in WB and IHC-P, IF, E, IP

Description: A Monoclonal antibody against Human FGF2 / Basic FGF (clone 3D9). The antibodies are raised in Mouse and are from clone 3D9. This antibody is applicable in WB and IHC-P, IF